Biography:Margaret Gamalo
Margaret (Meg) Gamalo-Siebers is a Filipino-American biostatistician and drug development executive specializing in inflammation and immunology. She works for Pfizer as vice president – biostatistics, global product development – inflammation and immunology, and is editor-in-chief of the Journal of Biopharmaceutical Statistics.[1][2]
Education and career
Gamalo earned a master's degree in applied mathematics and operations research from the University of the Philippines. She completed a Ph.D. in statistics at the University of Pittsburgh,[3] in 2006.[4]
She worked in the Center for Drug Evaluation and Research at the US Food and Drug Administration, and as a principal research scientist and research advisor for global statistical sciences at Eli Lilly, before taking her present position at Pfizer.[1][3][4]
Recognition
Gamalo was named as a Fellow of the American Statistical Association, in the 2023 class of fellows.[5]
References
- ↑ 1.0 1.1 Seifu, Yodit; Chang, Victoria; Lin, Junjing (December 1, 2020), "An Interview with Margaret Gamalo, Editor of JBS", Amstat News (American Statistical Association), https://magazine.amstat.org/blog/2020/12/01/interview-editor-of-jbs/, retrieved 2023-10-16
- ↑ "Editorial board", Journal of Biopharmaceutical Statistics web site (Taylor & Francis), https://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=lbps20, retrieved 2023-10-16
- ↑ 3.0 3.1 Schacht, Alexander, "How to combine a control arm with RWE data: Interview with Margaret Gamalo", The Effective Statistician, https://theeffectivestatistician.com/how-to-combine-a-control-arm-with-rwe-data/, retrieved 2023-10-16
- ↑ 4.0 4.1 Past graduates, University of Pittsburgh Department of Statistics, https://www.stat.pitt.edu/alumni/past-graduates, retrieved 2023-10-16
- ↑ 2023 ASA Fellows, American Statistical Association, https://www.amstat.org/docs/default-source/amstat-documents/pdfs/fellows/Fellows2023.pdf, retrieved 2023-10-16
 |  |
